State Street’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $33K | Hold |
|
|||||
|
2023
Q3 | $44.8K | Hold |
|
|||||
|
2023
Q2 | $103K | Sell |
|
|||||
|
2023
Q1 | $751K | Buy |
|
|||||
|
2022
Q4 | $955K | Buy |
|
|||||
|
2022
Q3 | $6.05M | Buy |
|
|||||
|
2022
Q2 | $4.42M | Buy |
|
|||||
|
2022
Q1 | $4.6M | Buy |
|
|||||
|
2021
Q4 | $2.83M | Sell |
|
|||||
|
2021
Q3 | $3.71M | Buy |
|
|||||
|
2021
Q2 | $4.61M | Buy |
|
|||||
|
2021
Q1 | $4.52M | Buy |
|
|||||
|
2020
Q4 | $6.12M | Buy |
|
|||||
|
2020
Q3 | $3.76M | Buy |
|
|||||
|
2020
Q2 | $4.42M | Buy |
|
|||||
|
2020
Q1 | $3.13M | Buy |
|
|||||
|
2019
Q4 | $6.59M | Buy |
|
|||||
|
2019
Q3 | $4.42M | Buy |
|
|||||
|
2019
Q2 | $3.81M | Buy |
|
|||||
|
2019
Q1 | $219K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $379K | Buy |
|
|||||
|
2016
Q4 | $356K | Buy |
|
|||||
|
2016
Q3 | $357K | Buy |
|
|||||
|
2016
Q2 | $428K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $480K | Buy |
|